Skip to main content
Medica logo

Medica — Investor Relations & Filings

Ticker · MDC ISIN · IT0005460149 LEI · 815600FE16FA9F3E2296 XMIL Manufacturing
Open in API
Filings indexed 114 across all filing types
Latest filing 2022-02-04 Earnings Release
Country IT Italy
Listing XMIL MDC

About Medica

https://www.medica.it/

Medica S.p.A. is a company specializing in advanced purification technologies. Its core business is the development and production of products for blood purification, with applications in dialysis, Continuous Renal Replacement Therapy (CRRT), and apheresis. The company's medical product portfolio includes polysulfone membranes, dialysis filters, hemofilters, and blood lines. It has expanded its expertise into other medical fields such as cardiology, oncology surgery, organ transplantation, urology, and gastroenterology. Leveraging its filtration know-how, Medica also operates a water purification division that produces hollow fiber membranes. Additionally, the company offers turnkey solutions for the biomedical sector, providing vertically integrated services from research and development to manufacturing, industrial automation, and regulatory management.

Recent filings

Filing Released Lang Actions
Medica SpA - Ricavi Netti e Posizione Finanziaria Netta preconsuntivi consolidati al 31 dicembre 2021
Earnings Release Classification · 100% confidence The document is titled "Comunicato stampa" (Press Release) and provides preliminary consolidated financial results for the year 2021 (Fatturato consolidato 2021 pari a 43,8 milioni di euro). It details revenue, net financial position, and mentions that the official audited financial statements will be released on March 30, 2022. This structure—a press release announcing preliminary annual figures before the formal filing—is characteristic of an Earnings Release (ER). It is not the full 10-K, nor is it a transcript (CT) or a formal audit report (AR). Since it announces the key financial highlights for the period, ER is the most appropriate classification. FY 2021
2022-02-04 Italian
Medica S.p.A. - Financial calendar 2022
Report Publication Announcement Classification · 98% confidence The document is explicitly titled "Press Release" and its primary content is the announcement of the company's "FINANCIAL CALENDAR 2022". This calendar lists future dates for the release of preliminary results, approval of financial statements, and the Ordinary Shareholders' Meeting. This type of announcement, detailing the schedule for future report publications, aligns best with the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. It is not the report itself (like 10-K or IR), nor is it a transcript (CT) or an earnings release (ER) containing actual results.
2022-01-21 Italian
Medica S.p.A. - Calendario finanziario 2022
Report Publication Announcement Classification · 95% confidence The document is titled "CALENDARIO FINANZIARIO 2022" (Financial Calendar 2022) and is explicitly labeled as a "Comunicato stampa" (Press Release). It details future dates for key corporate events, such as the presentation of preliminary results, board approval of the annual and semi-annual financial statements, and the Annual General Meeting (Assemblea ordinaria degli Azionisti). Since the document's primary purpose is to announce the schedule of future financial reporting and shareholder meetings, it functions as an announcement about upcoming corporate events rather than being the report itself (like 10-K or IR). This fits best under the category for announcing the publication or timing of reports, which is Report Publication Announcement (RPA). Although it contains some company profile information, the core content is the schedule announcement.
2022-01-21 Italian
Medica S.p.A. - Full exercise of the Greenshoe option and final communication of the stabilization activities
Report Publication Announcement Classification · 99% confidence The document is explicitly labeled as a "Press Release" and announces the "FULL EXERCISE OF THE GREENSHOE OPTION AND FINAL COMMUNICATION OF THE STABILIZATION ACTIVITIES" related to an Offer of ordinary shares. The content details the exercise of 100,000 shares for a total countervalue of EUR 2,700,000, resulting in a final placement size and free float percentage. This activity—the finalization of share placement/offering mechanics, including stabilization and greenshoe options—is directly related to capital raising or share issuance activities. This fits best under the 'Capital/Financing Update' category (CAP), as it finalizes the terms of a recent share offering. It is not a general regulatory filing (RNS) because it is highly specific to a financing event, nor is it a general share issue announcement (SHA), but rather the conclusion of a placement process.
2021-11-05 English
Medica S.p.A. - Esercizio integrale dell'opzione greenshoe e comunicazione finale dell'attività di stabilizzazione
Capital/Financing Update Classification · 95% confidence The document is titled "Comunicato stampa" (Press Release) and announces the finalization of a stabilization activity related to a share offering, specifically the full exercise of the 'greenshoe' option. This relates to capital market activities, share placement, and financing structure changes following an offering. While it touches upon capital structure, the core event is the finalization of the share placement/stabilization process. This fits best under Capital/Financing Update (CAP) as it details the final size and structure resulting from the offering, or potentially Regulatory Filings (RNS) if it were a generic announcement. Given the specific nature regarding the greenshoe exercise and final placement size, CAP is the most appropriate fit over the general RNS fallback. It is not a full 10-K, IR, or ER, but a specific corporate action update.
2021-11-05 Italian
MEDICA S.P.A. - First day of trading on Euronext Growth Milan
Regulatory Filings Classification · 100% confidence The document is explicitly labeled as a "Press Release" announcing the "FIRST DAY OF TRADING ON EURONEXT GROWTH MILAN" for Medica S.p.A. on November 3, 2021. This type of announcement, detailing the listing event, opening price, trading volume, and involved advisors, is a corporate action announcement related to capital markets activity, but it is not a standard periodic financial report (like 10-K or IR) or a specific financing update (CAP). It is a general corporate announcement regarding market listing. Since it doesn't fit perfectly into the defined categories like DIV, SHA, or POS, and it's not a transcript (CT) or an earnings release (ER), the most appropriate general category for a significant, non-standard regulatory/market event announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS), as it pertains to market operations and disclosure. However, given the context of listing and capital structure change, it is closely related to financing/capital events. Since the document is a press release announcing a market event (listing), and not a formal filing like a prospectus or a specific capital change notice, RNS is the best fit as a general disclosure mechanism for such news. It is not a proxy statement (PSI), director dealing (DIRS), or management change (MANG). The document is short and acts as an announcement, not the full report itself.
2021-11-03 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.